Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott P Levick

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 9, 2023
Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetesGiselle C Meléndez, Kylie Kavanagh, Nazli Gharraee, et al.
Cells|October 23, 2021
Replacement of Lost Substance P Reduces Fibrosis in the Diabetic Heart by Preventing Adverse Fibroblast and Macrophage Phenotype ChangesAlexander Widiapradja, Ainsley O Kasparian, Samuel L McCaffrey, et al.
American Journal of Physiology. Cell Physiology|May 27, 2024
Cellular metabolism of substance P produces neurokinin-1 receptor peptide agonists with diminished cyclic AMP signalingTamas Kriska, Jayashree Natarajan, Anja Herrnreiter, et al.
Heart, Lung & Circulation|September 13, 2018
Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac FibroblastsScott P Levick, David R Soto-Pantoja, Jianli Bi, et al.
Journal of Cardiovascular Pharmacology|February 2, 2011
Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive ratsVincent Chan, Andrew Fenning, Scott P Levick, et al.
British Journal of Pharmacology|June 17, 2025
Polypharmacy in mice disrupts left ventricular function and structure and promotes proteome reorganisation in an age- and sex-specific fashionTrang Tran, Kevin Winardi, Scott P Levick, et al.
British Journal of Pharmacology|April 25, 2026
Neurokinin-1 receptor activation protects against cardiac fibrosis, inflammation and diastolic dysfunction in type 2 diabetic miceAlexander Widiapradja, Heather Connery, Brody J Helmick, et al.
Scientific Reports|July 31, 2019
Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic HeartAlexander Widiapradja, Edward J Manteufel, Heather M Dehlin, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 9, 2023
Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetesGiselle C Meléndez, Kylie Kavanagh, Nazli Gharraee, et al.
Cells|October 23, 2021
Replacement of Lost Substance P Reduces Fibrosis in the Diabetic Heart by Preventing Adverse Fibroblast and Macrophage Phenotype ChangesAlexander Widiapradja, Ainsley O Kasparian, Samuel L McCaffrey, et al.
American Journal of Physiology. Cell Physiology|May 27, 2024
Cellular metabolism of substance P produces neurokinin-1 receptor peptide agonists with diminished cyclic AMP signalingTamas Kriska, Jayashree Natarajan, Anja Herrnreiter, et al.
Heart, Lung & Circulation|September 13, 2018
Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac FibroblastsScott P Levick, David R Soto-Pantoja, Jianli Bi, et al.
Journal of Cardiovascular Pharmacology|February 2, 2011
Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive ratsVincent Chan, Andrew Fenning, Scott P Levick, et al.
British Journal of Pharmacology|June 17, 2025
Polypharmacy in mice disrupts left ventricular function and structure and promotes proteome reorganisation in an age- and sex-specific fashionTrang Tran, Kevin Winardi, Scott P Levick, et al.
British Journal of Pharmacology|April 25, 2026
Neurokinin-1 receptor activation protects against cardiac fibrosis, inflammation and diastolic dysfunction in type 2 diabetic miceAlexander Widiapradja, Heather Connery, Brody J Helmick, et al.
Scientific Reports|July 31, 2019
Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic HeartAlexander Widiapradja, Edward J Manteufel, Heather M Dehlin, et al.
Pageof 5